We are live on
!
Find out more
TC
Truvestments Capital Portfolio holdings
AUM
$554M
1-Year Est. Return
32.49%
This Fund
S&P 500
This Quarter
Est. Return
+7.39%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$9.15M
(-6%)
Cap. Flow
-$18.1M
Cap. Flow
% of AUM
-12.5%
Top 10 Holdings %
Top 10 Hldgs %
26.79%
Holding
704
New
1
Increased
73
Reduced
49
Closed
564
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$269K |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$197K |
| 3 |
Altria Group
MO
|
+$144K |
| 4 |
MPT
Medical Properties Trust
MPT
|
+$127K |
| 5 |
ExxonMobil
XOM
|
+$117K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$582K |
| 2 |
Marathon Petroleum
MPC
|
+$200K |
| 3 |
AerCap
AER
|
+$196K |
| 4 |
XPO
XPO
|
+$195K |
| 5 |
Campbell Soup
CPB
|
+$186K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.31% |
| 2 | Healthcare | 10.05% |
| 3 | Consumer Staples | 8.95% |
| 4 | Communication Services | 7.78% |
| 5 | Industrials | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
General Dynamics
GD
$106B
| $952K | 0.66% |
5,396
+99
| +2% | +$17.8K |
|
52
Vanguard High Dividend Yield ETF
VYM
$82.8B
| $928K | 0.64% |
9,897
-558
| -5% | -$50.6K |
|
53
United Parcel Service
UPS
$88.9B
| $899K | 0.62% |
7,681
+561
| +8% | +$66.4K |
|
54
Coca-Cola
KO
$375B
| $881K | 0.61% |
15,924
+64
| +0.4% | +$3.44K |
|
55
Boeing
BA
$185B
| $874K | 0.61% |
2,682
+3
| +0.1% | +$1.06K |
|
56
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$8.78B
| $859K | 0.59% |
21,776
+255
| +1% | +$9.84K |
|
57
Tanger
SKT
$4.52B
| $835K | 0.58% |
56,664
+4,125
| +8% | +$64.5K |
|
58
Medtronic
MDT
$112B
| $830K | 0.57% |
7,318
-40
| -0.5% | -$4.39K |
|
59
Essential Utilities
WTRG
$11.4B
| $817K | 0.57% |
17,401
-783
| -4% | -$35.3K |
|
60
Enterprise Products Partners
EPD
$81.7B
| $788K | 0.55% |
27,980
-1,291
| -4% | -$35K |
|
61
Brookfield Renewable
BEP
$9.96B
| $786K | 0.54% |
31,613
+2,270
| +8% | +$53.6K |
|
62
JPMorgan Chase
JPM
$950B
| $786K | 0.54% |
5,637
-699
| -11% | -$89.7K |
|
63
Oneok
OKE
$54.5B
| $783K | 0.54% |
10,344
+473
| +5% | +$33.8K |
|
|
CONE
64
DELISTED
CyrusOne Inc Common Stock
CONE
| $782K | 0.54% |
11,957
+353
| +3% | +$24.2K |
|
65
Blackstone Mortgage Trust
BXMT
$2.38B
| $761K | 0.53% |
20,457
+2,183
| +12% | +$79.4K |
|
66
Lincoln National
LNC
$8.81B
| $745K | 0.52% |
12,626
-3
| -0% | -$177 |
|
|
MIC
67
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $735K | 0.51% |
17,152
+1,316
| +8% | +$54.3K |
|
68
NVIDIA
NVDA
$5.42T
| $733K | 0.51% |
124,560
+7,160
| +6% | +$37.2K |
|
69
Ventas
VTR
$47.9B
| $687K | 0.48% |
11,901
+884
| +8% | +$55.5K |
|
70
Quest Diagnostics
DGX
$26.3B
| $677K | 0.47% |
6,342
-128
| -2% | -$13.3K |
|
71
Dow Inc
DOW
$21.2B
| $660K | 0.46% |
12,055
+1,989
| +20% | +$103K |
|
72
Invesco QQQ Trust
QQQ
$484B
| $647K | 0.45% |
3,043
+33
| +1% | +$6.61K |
|
73
Sysco
SYY
$40.3B
| $645K | 0.45% |
7,540
-659
| -8% | -$53.4K |
|
74
Brookfield Infrastructure Partners
BIP
$18B
| $641K | 0.44% |
21,539
+2,222
| +12% | +$66.6K |
|
75
Emerson Electric
EMR
$88.3B
| $635K | 0.44% |
8,329
-75
| -0.9% | -$5.41K |
|
Similar funds
CA
SVCM
CAM
TC
BT
QL
IQI
TCM
Truvestments Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Truvestments Capital held 704 positions worth $144M, down 6% from $154M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Truvestments Capital withdrew a net $18.1M in Q4 2019, closing 564 positions and reducing 49 holdings. Its most notable exit was Celgene Corp, an estimated $582K position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Truvestments Capital opened a new position in Vanguard FTSE Developed Markets ETF worth $204K.
- Truvestments Capital's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 4,627 shares worth $204K.
- Truvestments Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $269K increase.
- Truvestments Capital's biggest Q4 2019 reduction was Apple, cutting an estimated $151K.
- Truvestments Capital fully exited Celgene Corp in Q4 2019, selling an estimated $582K.
- Truvestments Capital's ten largest holdings make up 27% of its $144M portfolio in Q4 2019.
- Truvestments Capital opened 1 new position and closed 564 in Q4 2019.
- Truvestments Capital's portfolio value fell 6% quarter-over-quarter to $144M.
Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.